RAPIGLINIDE VOG 0.5 is a combination medication designed to manage blood glucose levels in individuals with type 2 diabetes. It combines Repaglinide, a meglitinide analog, and Voglibose, an alpha-glucosidase inhibitor. This formulation aims to improve glycemic control by targeting different mechanisms involved in glucose regulation.

How Does It Work?

• Repaglinide (0.5mg): Stimulates the pancreas to release insulin, reducing blood sugar levels after meals.
• Voglibose (0.3mg): Slows down carbohydrate absorption in the intestines, preventing post-meal spikes in blood glucose.

Uses

• Type 2 Diabetes Management: Helps maintain blood sugar levels within the target range.
• Postprandial Hyperglycemia: Reduces blood sugar spikes after meals, essential for overall glucose control.

What is RAPIGLINIDE VOG 0.5?

RAPIGLINIDE VOG 0.5 is a dual-action oral antidiabetic medication. By combining Repaglinide and Voglibose, it provides a comprehensive approach to managing postprandial blood glucose levels, making it effective for type 2 diabetes patients.

Side Effects

• Common: Hypoglycemia, gastrointestinal disturbances (diarrhea, nausea), headache.
• Serious: Severe hypoglycemia, allergic reactions, liver function abnormalities.

Safety Information

• Monitoring: Regular blood sugar monitoring is essential to avoid hypoglycemia.
• Diet and Exercise: Follow a balanced diet and exercise regimen as advised by your healthcare provider.
• Interactions: Inform your doctor about all medications and supplements you are taking to avoid potential interactions.
• Pregnancy and Breastfeeding: Consult your doctor before use if you are pregnant, planning to become pregnant, or breastfeeding.

If You Need More Information About   RAPIGLINIDE VOG 0.5   Click here